Therefore, we propose that a therapeutic approach able to target multiple pathways to stop the different signaling cascades driving AD pathogenesis including Aβ aggregation, Tau phosphorylation, oxidative stress and mitochondrial dysfunction could pose as an effective strategy. The gene discussed is MAPT; the disease is Alzheimer disease.